Slides
Page 1
H1 2025 FINANCIAL RESULTS August 19, 2025
Page 2
SAFE HARBOR STATEMENT Forward-looking statements involve risks. This company presentation contains various statements concerning the future performance of STRATEC. These statements are based on both assumptions and estimates. Although we are convinced that these forward-looking statements are realistic, we can provide no guarantee of this. This is because our assumptions involve risks and uncertainties which could result in a substantial divergence between actual results and those expected. It is not planned to update these forward-looking statements. 2H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025
Page 3
AGENDA 3H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 1. HI 2025 AT A GLANCE 2. FINANCIAL REVIEW 3. OUTLOOK 4. Q&A
Page 4
H1 2025 AT A GLANCE 4H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 HIGHLIGHTS AND ACHIEVEMENTS Return to sales growth thanks to high development activity and further stabilization in system demand Stable gross margin development overshadowed by negative currency effects Progress in development partnerships and significant upturn in the deal pipeline in the area of system development Full year outlook confirmed …. developments in H1/2025 inline with intra-year expectations
Page 5
FINANCIAL REVIEW 5H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 FINANCIALS AT A GLANCE 1 bps = basis points cc = at constant currency 1 To facilitate comparison, figures have been adjusted to exclude amortization resulting from purchase price allocations in the context of acquisitions and other non-recurring items (including one-off advisory expenses, fees, and restructuring expenses). 2 Restated pursuant to IAS 8. Change Q2/2024 2Q2/2025 Change H1/2024 2H1/2025 € 000s -1.0% (cc: +0.9%) 58,803 58,227 +5.2% (cc: +5.8%) 112,691 118,590 Sales -37.6% 10,834 6,765 -7.8% 17,426 16,070 Adjusted EBITDA -680 bps 18.4 11.6 -190 bps 15.5 13.6 Adjusted EBITDA margin (%) -55.1% 6,960 3,124 -14.1% 9,880 8,487 Adjusted EBIT -640 bps 11.8 5.4 -160 bps 8.8 7.2 Adjusted EBIT margin (%) -59.8% 4.539 1,823 -11.2% 5,603 4,978 Adjusted consolidated net income -59.5% 0.37 0.15 -10.9% 0.46 0.41 Adjusted basic earnings per share (in €) -71.0% 0.31 0.09 -36.4% 0.33 0.21 Basic earnings per share IFRS (in €)
Page 6
FINANCIAL REVIEW 6H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 ADJUSTMENTS H1/2025 Consolidated net income EBIT H1/2024 2H1/2025 € 000s 9,880 8,487 Adjusted EBIT Adjustments: --1,871 -1,617 PPA amortization -120 -1,551 Other 1 7,889 5,319 EBIT H1/2024 2H1/2025 € 000s 5.603 4,978 Adjusted consolidated net income 0.46 0.41 Adjusted earnings per share in € (basic) Adjustments: -1.871 -1,617 PPA amortization -120 -1,551 Other 1 434 792 Taxes on income 4,046 2,602 Consolidated net income 0.33 0.21 Earnings per share in € (basic) 1 Including one-off advisory expenses, fees, and restructuring e xpenses 2 Restated pursuant to IAS 8 1 Including one-off advisory expenses, fees, and restructuring e xpenses 2 Restated pursuant to IAS 8
Page 7
FINANCIAL REVIEW H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 SALES H1/2025 7 € 112.7 million € 118.6 million H1/2024 H1/2025 cc = at constant currency H1/2024 restated pursuant to IAS 8 As of June 30 +5.8% at cc YOY H1/2025 sales +5.8% yoy in constant currency to € 118.6 million • Resilient growth with Service Parts and consumables • Increased recognition of Development and service sales • Subdued ramp-up curves for newly launched products • Low but stabilizing demand for MDx systems following pandemic related disruptions
Page 8
FINANCIAL REVIEW 8H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 SALES BY OPERATING DIVISIONS H1/2025 35.8 52.3 24.0 0.7 34.9 53.7 28.8 1.2 0 10 20 30 40 50 60 Systems Service parts & consumables Development & services Others H1/2024 H1/2025 +75.2% (+76.8% at cc) +2.8% (+3.4% at cc) +19.9% (+20.5% at cc) Sales in € million 21.3% 24.2% 46.4% 45.3% 31.8% 29.5% 0% 20% 40% 60% 80% 100% H1/2024 H1/2025 Systems Service parts and consumables Development & services Others In % of total sales -2.4% (-2.2% at cc) cc = at constant currency H1/2024 restated pursuant to IAS 8 As of June 30
Page 9
FINANCIAL REVIEW H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 Adj. EBIT ADJUSTED EBIT AND EBIT MARGIN H1/2025 9 € 9.9 million € 8.5 million 0 4 8 12 H1/2024 H1/2025 -14.1% YoY -160 bps YoY H1 2025 adj. EBIT -14.1% to 8.5 million € Margin -160 bps Y oY to 7.2% • Stable gross margin development despite lag of scale and subdued product mix in the systems business Gross margin at 26.9% (H1/2024: 27.1%) Efficiency measures and structural changes taking effect • Negative valuation effects resulting from currency translation of balance sheet items H1/2024 H1/2025 € 000s -5,560 -5,425 Research and development expenses -6,852 -6,507 Sales-related expenses -11,260 -12,988 General administrative expenses +9 -418 Income / Expenses from impairment of financial assets and contract assets +1,006 -1,298 Other operating income and expenses H1/2024 restated pursuant to IAS 8 As of June 30 Margin 8.8% Margin 7.2%
Page 10
FINANCIAL REVIEW H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 CASH FLOW AND NET DEBT 10 Change H1/2024 H1/2025 € 000s nm 17,381 -5,771 Cash flow – operating activities nm -8,773 -8,960 Cash flow – investment activities nm -11,627 -12,413 Cash flow – financing activities nm 8.608 -14.731 Free cash flow Change FY/2024 H1/2025 € 000s -60.4% 47,164 18,698 Cash +150 bps 54.5 56.0 Equity ratio (%) +26.3% 87,096 110,005 Net debt 10 • Operating cash flow dynamics burdened by high cash tax payments, decrease in trade payables and not yet materialized inventory reduction • Strong focus to reduce still elevated inventory levels going forward • Investment ratio 1 at 7.6% of sales below projected corridor for FY 2025 of 8.0% to 10.0% • Net debt / LTM adj. EBITDA at 2.3x (up from 1.8x at the end of FY 2024) • Negotiations on refinancing of existing bridge loan by a new syndicated loan is ongoing (closing slightly postponed; signing now expected for end of August ) 1 Total investments in intangible and tangible assets in % of sales FY/2024 H1/2025 € 000s 121,818 125,114 Inventories 41,578 40,357 Trade receivables 18,447 14,742 Trade payables
Page 11
OUTLOOK Consolidated sales for the 2025 financial year expected to grow in a low to medium single-digit percentage range on a constant-currency basis Current order forecasts from customers indicate increasing momentum in the systems business in the second half of the year 11 H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 FINANCIAL GUIDANCE FOR FISCAL YEAR 2025 Adjusted EBIT margin of 10.0% to 12.0% (FY 2024: 13.0%) Higher earnings contribution from higher-margin development and services sales expected for the fourth Quarter 2025 Better scale effects due to better utilization in the systems business within H2/2025 Investments in tangible and intangible assets combined of around 8.0% to 10.0% of sales (FY 2024: 7.1%) Higher investments for development projects and IT
Page 12
Maintaining cost discipline throughout the company given earnings improvement measures implemented Continue to grow footprint in selected market focus areas (High- Sensitivity Immunoassays, Advanced Imaging, Cell & Gene Therapy) Manage and process well filled M&A pipeline according to external growth and diversification strategy Execute deal pipeline regarding new development and manufacturing agreements Continue l everaging the combined customer base of both, STRATEC and Natech OUTLOOK 12 H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 FOCUS IN 2025 AND BEYOND Improve cash flow dynamics with strong focus on inventory efficiency
Page 13
WE ARE HAPPY TO SUPPORT 13 H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025
Page 14
STRATEC SE Gewerbestr. 37 75217 Birkenfeld Germany Phone +49 7082 7916-0 Fax +49 7082 7916-999 www.stratec.com CONTACT THANK YOU FOR YOUR ATTENTION CONTACT H1 2025 FINANCIAL RESULTS – AUGUST 19, 2025 14 Jan Keppeler, CFA Head of Investor Relations, Sustainability & Corporate Communications Phone +49 7082 7916-6515 j.keppeler@stratec.com